Harsha Gunawardena

Harsha Gunawardena obtained his PhD from Purdue University where he conducted research in advance instrumentation including multi-source ion trap MS to facilitate the manipulation, reactivity, and dissociation of gaseous ions. He developed mechanistic models to understand electron transfer (ET) processes based on the Landau-Zener theory and applied to examine ETD. He developed an energy deposition framework using RRKM theory to understand the dynamics and energetics of ion-ion complexes. He was a NIH fellow at the Lineberger Comprehensive Cancer Center, UNC school of medicine where he applied quantitative mass spectrometry technologies for sensitive and accurate proteomic measurements. He was involved in large-scale global shotgun protein expression and site-specific post-translation modification (e.g., phosphorylation, oxidative modifications) analysis for over a 100 projects. He was also a member of the CPTAC program, ENCODE consortium, NIH roadmap for epigenetics while at UNC. His research interest include droplet reactions, ultra-fast analysis, and proteomics technology development. Currently he leads the proteomics group at Johnson & Johnson.